Advertisement

Latest News

Prospecting the IL-33 Pathway for COPD Care, with Nicola Hanania, MD, MS

6 hours ago

Hanania explains how IL-33 inhibitors including itepekimab and astegolimab may uniquely benefit COPD exacerbation.

CeleBrate: Zalunfiban Administration at First Contact Improves STEMI Outcomes, With C. Michael Gibson, MD

7 hours ago

Gibson discusses the promising improvements to the composite primary endpoint of mortality, stroke, and recurrent MI as a result of zalunfiban treatment.

2025 in Hepatology: New MASLD Therapies, HBV Updates, and More

8 hours ago

Recent advancements in hepatology highlight new medications for metabolic dysfunction and liver diseases, promising improved patient outcomes and treatment options.

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

11 hours ago

In this analysis, investigators explored potential impacts of antibiotic exposure on the persistence of biologic treatments in patients living with psoriasis.

Bettering CT Scan Rates in Pulmonology, with Graham Barr, MD, DrPH

11 hours ago

Barr discusses the means to encourage systemic adoption of low dose CT scans to help curb the deadliest cancer in the US.

Advertisement
Advertisement